The Scientist

» approvals

Most Recent

image: Drug Approval Timeline Same as 20 Years Ago

Drug Approval Timeline Same as 20 Years Ago

By | January 9, 2017

A report finds that new medications still take about 12 years to go from patent to patient.

0 Comments

image: Planning for the Next Ebola Outbreak

Planning for the Next Ebola Outbreak

By | January 20, 2016

A public-health nonprofit and an international drugmaker team up to stockpile hundreds of thousands of doses of a promising vaccine and to speed along the approval process.

0 Comments

image: Drug Produced in GM Chicken Approved

Drug Produced in GM Chicken Approved

By | December 10, 2015

The US Food and Drug Administration greenlights a rare-disease drug that is produced in the eggs of genetically modified chickens.

1 Comment

image: Clinical Trial Data Underreported: Study

Clinical Trial Data Underreported: Study

By | November 16, 2015

One-third of the human experiments for approved drugs failed transparency requirements.

0 Comments

image: Doctor Who Blocked Thalidomide Dies

Doctor Who Blocked Thalidomide Dies

By | August 11, 2015

Frances Oldham Kelsey, a physician who halted use of a drug that caused birth defects in babies, has passed away at age 101.

0 Comments

image: FDA OKs Herpes Blood Test

FDA OKs Herpes Blood Test

By | July 6, 2015

The US Food and Drug Administration approves Theranos’s fingerstick test for herpes.

0 Comments

image: Device Trials Go Unpublished

Device Trials Go Unpublished

By | June 24, 2015

Just half of the clinical studies used to gain premarket approval for cardiac devices ever make it into the scientific literature.

0 Comments

image: Lazarus Drugs

Lazarus Drugs

By | February 1, 2015

While some drugs sail through development, others suffer setbacks, including FDA rejections, before reaching the market.  

1 Comment

image: Genetic Test Could Replace Pap Smear

Genetic Test Could Replace Pap Smear

By | April 25, 2014

The US Food and Drug Administration approves a cervical test for human papillomavirus to be used as a primary cancer screening tool.

0 Comments

image: Inconsistent Evidence

Inconsistent Evidence

By | January 22, 2014

More than a third of US drug approvals are based on a single large clinical trial, while others require more in-depth study, according to a new report.

0 Comments

Popular Now

  1. Opinion: Why I Published in a Predatory Journal
    News & Opinion Opinion: Why I Published in a Predatory Journal

    My “colleagues” and I at the fictitious Arthur Vandelay Urological Research Institute were surprised to find our bogus “uromycitisis” case report swiftly accepted, with only minor revisions requested.

  2. Consilience, Episode 3: Cancer, Obscured
  3. March for Science: Dispatches from Washington, DC
  4. Record-Setting Corn Grows 45 Feet Tall
AAAS